NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical- ...

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to alleged false statements and misleading information regarding the launch of its Inspire V device, which has resulted in significant financial losses for investors [1][4][10]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc." and covers the period from August 6, 2024, to August 4, 2025 [1]. - Investors have until January 5, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Inspire Medical and its executives violated the Securities Exchange Act of 1934 [1]. Group 2: Allegations Against Inspire Medical - The lawsuit claims that the launch of the Inspire V device was poorly executed, with significant surplus inventory and reluctance from providers to adopt the new treatment [4]. - It is alleged that Inspire Medical failed to complete essential tasks necessary for a successful launch, contrary to their assurances to investors [4]. - On August 4, 2025, Inspire Medical disclosed that the launch faced an "elongated timeframe" due to undisclosed challenges, including incomplete training and onboarding at implanting centers [5]. Group 3: Financial Impact - Following the negative news regarding the Inspire V launch, Inspire Medical reduced its 2025 earnings guidance by over 80% [5]. - The stock price of Inspire Medical declined by more than 32% after the announcement of these issues [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Inspire Medical Systems, Inc. common stock during the specified Class Period, indicating potential misrepresentation by the company regarding its product demand and launch steps [1][5]. Group 1: Lawsuit Details - The class action lawsuit is focused on common stock purchasers of Inspire Medical Systems between August 6, 2024, and August 4, 2025 [1]. - The lawsuit claims that defendants misrepresented key facts about the Inspire V sleep apnea device, including actual market demand and necessary steps for its launch, leading to investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased Inspire Medical common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Inspire investments, you have until January 5, 2025 to request lead plaintiff appointm ...

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit on behalf of investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period, highlighting potential misrepresentation regarding the market demand for the Inspire V sleep apnea device [2][6]. Group 1: Class Action Details - The class action lawsuit pertains to purchases made between August 6, 2024, and August 4, 2025, and aims to address alleged misleading statements made by the defendants regarding the demand and launch of the Inspire V device [2][6]. - Investors who purchased Inspire Medical common stock during the Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Process and Participation - Interested investors can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for January 5, 2026 [4][7]. - It is noted that no class has been certified yet, meaning investors are not represented by counsel unless they choose to retain one [8]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its success in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [5].

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Co ...

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors in Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”) securities that a securities class action has been filed on behalf of all investors who purchased shares between August 6, 2024 and August 4, 2025 (the “Class Period”). Investors have until January 5, 2026 to seek appointment as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Allegations The complaint filed allege ...

Core Insights - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. regarding alleged violations of federal securities laws related to misleading statements about the Inspire V device launch [3][6] - Investors who suffered losses from August 6, 2024, to August 4, 2025, are encouraged to contact the firm to discuss their legal options before the January 5, 2026, deadline for seeking lead plaintiff status in a federal securities class action [2][3] Company Performance - Inspire Medical announced significant setbacks in the launch of its Inspire V device on August 4, 2025, citing delays due to incomplete training and onboarding at treatment centers [7] - The company faced billing and reimbursement challenges, with necessary software updates for claims processing not effective until July 1, 2025, leading to continued use of the older Inspire IV system [7] - Demand for the Inspire V device was reported as weak, resulting in excess inventory and a drastic cut in 2025 earnings guidance by over 80% [8] Market Impact - Following the announcement of these issues, Inspire Medical's stock price plummeted by more than 32%, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025, erasing approximately $1.2 billion in market capitalization [8]

San Diego, California--(Newsfile Corp. - November 12, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-0 ...

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Virginia on behalf of all persons or entities who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: INSP) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). The Complaint alleges throughout the Class Period, Stride told the market that it was “o ...